Search Results 1901-1910 of 19674 for hemoglobin

  1. Ixazomib Citrate in Treating Patients With Relapsed Multiple Myeloma That Is Not Refractory to Bortezomib - Mayo Clinic

    Hemoglobin ≥ 8.0 g/dL;; Total bilirubin ≤ 1.5 x the upper limit of the normal range (ULN);; Aspartate aminotransferase (AST) ≤ 3 x ULN;; Alanine ...

  2. FrαDcs Or Placebo For Patients With Advanced Stage Ovarian Cancer - Mayo Clinic

    Participation eligibility · Hemoglobin ≥ 8.5 g/dL; · Absolute neutrophil count (ANC) ≥ 1000/mm3; · Platelet count ≥ 75,000/mm3; · Lymphocytes ≥ 0.3 x 109/L;.

  3. Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25 - Mayo Clinic

    - Hemoglobin less than 10 g/dL; - Total bilirubin greater than ULN (upper limit of normal) for the lab or greater than 1.5 x ULN for patients who have a ...

  4. A Multi-center Trial to Evaluate Multiple Regimens in Metastatic Pancreatic Cancer - Mayo Clinic

    - Hemoglobin ≥ the lower limit of normal (LLN) or 9g/dL. - Platelets ≥ 100,000/mm^3. - Serum creatinine ≤ 1.0 x upper limit normal (ULN), or calculated ...

  5. Tucatinib and Trastuzumab for Patients with HER2-positive Metastatic Colorectal Cancer - Mayo Clinic

    Hemoglobin ≥ 8.0 g/dL;; Total bilirubin ≤ 1.5 × upper limit of normal (ULN). Subjects with known history of Gilbert's Syndrome and normal direct bilirubin ...

  6. Study Of Chemotherapy Plus Ipatasertib For People With Solid Tumors With AKT Mutations, A ComboMATCH Treatment Trial - Mayo Clinic

    ... hemoglobin (Hb)A1c, suggesting poorly controlled diabetes - Participants who are on a stable dose of oral diabetes medication >= 2 weeks prior to initiation ...

  7. Study to Evaluate the Safety, Tolerability and Antitumor Activity of Anti-B7-H3 Car-T Cell Injection (TX103) in Subjects With Recurrent or Progressive Grade 4 Glioma - Mayo Clinic

    Hematological function: Absolute neutrophil count (ANC) ≥ 1.5×109 /L, hemoglobin (Hb) ≥ 90g/L, platelet count (PLT) ≥ 100×109 /L, absolute lymphocytes ...

  8. Comparing Capecitabine and Temozolomide in Combination to Lutetium Lu 177 Dotatate in Patients With Advanced Pancreatic Neuroendocrine Tumors - Mayo Clinic

    Hemoglobin ≤ 9.0 g/dL. Creatinine ≤ 1.5 x upper limit of normal (ULN) OR calculated (calc.) creatinine clearance ≤ 30 mL/min (calculated by the Cockcroft ...

  9. Study Of The Bria-IMT Regimen And CPI Vs Physicians' Choice In Advanced Metastatic Breast Cancer. (BRIA-ABC) - Mayo Clinic

    Absolute granulocyte count \<1000; platelets \<80,000; hemoglobin ≤ 7 g/L. 10. Bilirubin ≥ 2 × ULN unless conjugated bilirubin ≤ ULN; alkaline ...

  10. Testing The Role Of DNA Released From Tumor Cells Into The Blood In Guiding The Use Of Immunotherapy After Surgical Removal Of The Bladder, Kidney, Ureter, And Urethra For Urothelial Cancer Treatment, MODERN Study - Mayo Clinic

    PRE-REGISTRATION: Hemoglobin >= 8 g/dL. PRE-REGISTRATION: Creatinine =< 1.5 x upper limit of normal (ULN) or calculated (calc.) creatinine clearance > 30 mL ...